Nasrat always wanted to List to Nasdaq but I do not know if you heard, the stock was kept down under 5 cents for years - artificially - so it made it very hard for him to do so.
It is true that he said when we get to 15-25 cents levels we will go to Nasdaq - but when you align 6 new drugs in 8 months, and you move to needle movers, the best strategy is to focus on growth and Profit.
It is not yet the time to buy back stock - each $ will bring more friends if invested wisely in R&D,
We will see an listing to NASDAQ in due time - organically.
Market Data 
Markets 
AI
